Microscopic colitis patients have increased proportions of Ki67+ proliferating and CD45RO+ active/memory CD8+ and CD4+8+ mucosal T cells

Journal of Crohn's and Colitis

Volumn 7, Issue 9, 2013, Pages 694-705

  Kumawat, Ashok Kumar ^a   Strid, Hilja ^a,b   Elgbratt, Kristina ^a   Tysk, Curt ^a,b   Bohr, Johan ^a,b   Hultgren Hörnquist, Elisabeth ^a  

^a ÖREBRO UNIVERSITY   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Collagenous colitis; ; Flow cytometry; ; Intraepithelial lymphocytes; Lamina propria lymphocytes; ; Lymphocytic colitis;

Indexed keywords

BUDESONIDE; CD4 ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLAGENOUS COLITIS; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE EPITHELIUM; LAMINA PROPRIA; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC COLITIS; MALE; MEMORY T LYMPHOCYTE; MICROSCOPIC COLITIS; MUCOSA CELL; PHENOTYPE; PRIORITY JOURNAL; REMISSION;

COLLAGENOUS COLITIS;; FLOW CYTOMETRY;; INTRAEPITHELIAL LYMPHOCYTES; LAMINA PROPRIA LYMPHOCYTES;; LYMPHOCYTIC COLITIS;;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD4; ANTIGENS, CD45; ANTIGENS, CD8; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; COLITIS, ULCERATIVE; FEMALE; FLOW CYTOMETRY; HUMANS; INTESTINAL MUCOSA; KI-67 ANTIGEN; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PHENOTYPE; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84881557685     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.08.014     Document Type: Article

References (42)

1. Tysk C., Bohr J., Nyhlin N., Wickbom A., Eriksson S. Diagnosis and management of microscopic colitis. World J Gastroenterol 2008, 14(48):7280-7288.
2. Pardi D.S., Kelly C.P. Microscopic colitis. Gastroenterology 2011, 140(4):1155-1165.
3. Leffler D.A., Dennis M., Hyett B., Kelly E., Schuppan D., Kelly C.P. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol 2007, 5(4):445-450.
4. Narvaez J., Montala N., Busquets-Perez N., Nolla J.M., Valverde J. Collagenous colitis and spondylarthropathy. Arthritis Rheum 2006, 55(3):507-512.
5. Ekiz F., Coban S., Savas B., Goren D., Ensari A., Ormeci N. Collagenous colitis in a patient with systemic sclerosis: a rare entity. J Natl Med Assoc 2007, 99(6):681-682.
6. Jarnerot G., Tysk C., Bohr J., Eriksson S. Collagenous colitis and fecal stream diversion. Gastroenterology 1995, 109(2):449-455.
7. Mosnier J.F., Larvol L., Barge J., Dubois S., De La Bigne G., Henin D., et al. Lymphocytic and collagenous colitis: an immunohistochemical study. Am J Gastroenterol 1996, 91(4):709-713.
8. Johrens K., Grunbaum M., Anagnostopoulos I. Differences in the T-bet and GATA-3 expression patterns between lymphocytic colitis and coeliac disease. Virchows Arch 2010, 457(4):451-456.
9. Tagkalidis P.P., Gibson P.R., Bhathal P.S. Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol 2007, 60(4):382-387.
10. Wagner M., Lampinen M., Sangfelt P., Agnarsdottir M., Carlson M. Budesonide treatment of patients with collagenous colitis restores normal eosinophil and T-cell activity in the colon. Inflamm Bowel Dis 2010, 16(7):1118-1126.
11. Levy A.M., Yamazaki K., Van Keulen V.P., Burgart L.J., Sandborn W.J., Phillips S.F., et al. Increased eosinophil infiltration and degranulation in colonic tissue from patients with collagenous colitis. Am J Gastroenterol 2001, 96(5):1522-1528.
12. Taha Y., Carlson M., Thorn M., Loof L., Raab Y. Evidence of local eosinophil activation and altered mucosal permeability in collagenous colitis. Dig Dis Sci 2001, 46(4):888-897.
13. Andresen L., Jorgensen V.L., Perner A., Hansen A., Eugen-Olsen J., Rask-Madsen J. Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut 2005, 54(4):503-509.
14. Perner A., Nordgaard I., Matzen P., Rask-Madsen J. Colonic production of nitric oxide gas in ulcerative colitis, collagenous colitis and uninflamed bowel. Scand J Gastroenterol 2002, 37(2):183-188.
15. Olesen M., Middelveld R., Bohr J., Tysk C., Lundberg J.O., Eriksson S., et al. Luminal nitric oxide and epithelial expression of inducible and endothelial nitric oxide synthase in collagenous and lymphocytic colitis. Scand J Gastroenterol 2003, 38(1):66-72.
16. Menconi M.J., Unno N., Smith M., Aguirre D.E., Fink M.P. Nitric oxide donor-induced hyperpermeability of cultured intestinal epithelial monolayers: role of superoxide radical, hydroxyl radical, and peroxynitrite. Biochim Biophys Acta 1998, 1425(1):189-203.
17. Tysk C., Wickbom A., Nyhlin N., Eriksson S., Bohr J. Recent advances in diagnosis and treatment of microscopic colitis. Ann Gastroenterol 2011, 24(4):253-262.
18. Stange E.F., Travis S.P., Vermeire S., Reinisch W., Geboes K., Barakauskiene A., et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2008, 2(1):1-23.
19. Cheroutre H., Lambolez F., Mucida D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol 2011, 11(7):445-456.
20. van Wijk F., Cheroutre H. Intestinal T cells: facing the mucosal immune dilemma with synergy and diversity. Semin Immunol 2009, 21(3):130-138.
21. Gibbons D.L., Spencer J. Mouse and human intestinal immunity: same ballpark, different players; different rules, same score. Mucosal Immunol 2011, 4(2):148-157.
22. Lazenby A.J., Alieniello R.G., Fox W.M., Giardiello F.M., Yardley J.H. T cell receptors in collagenous and lymphocytic colitis. Gastroenterology 1990, 98:A459.
23. Armes J., Gee D.C., Macrae F.A., Schroeder W., Bhathal P.S. Collagenous colitis: jejunal and colorectal pathology. J Clin Pathol 1992, 45(9):784-787.
24. Ge Y., Rampy B.A., Wang H.L., Xiao S.Y. Reduced CD1d expression in colonic epithelium in microscopic colitis. Appl Immunohistochem Mol Morphol 2006, 14(3):309-313.
25. Bai S., Siegal G.P., Jhala N.C. Foxp3 expression patterns in microscopic colitides: a clinicopathologic study of 69 patients. Am J Clin Pathol 2012, 137(6):931-936.
26. Masopust D., Jiang J., Shen H., Lefrancois L. Direct analysis of the dynamics of the intestinal mucosa CD8 T cell response to systemic virus infection. J Immunol 2001, 166(4):2348-2356.
27. Bohr J., Nordfelth R., Jarnerot G., Tysk C. Yersinia species in collagenous colitis: a serologic study. Scand J Gastroenterol 2002, 37(6):711-714.
28. Erim T., Alazmi W.M., O'Loughlin C.J., Barkin J.S. Collagenous colitis associated with Clostridium difficile: a cause effect?. Dig Dis Sci 2003, 48(7):1374-1375.
29. Munch A., Soderholm J.D., Ost A., Strom M. Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment. Am J Gastroenterol 2009, 104(3):679-685.
30. Blumberg R.S. Characterization of CD1d in mucosal immune function: an immunotherapeutic target for inflammatory bowel disease. Keio J Med 2001, 50(1):39-44.
31. Campbell N.A., Kim H.S., Blumberg R.S., Mayer L. The nonclassical class I molecule CD1d associates with the novel CD8 ligand gp180 on intestinal epithelial cells. J Biol Chem 1999, 274(37):26259-26265.
32. Allez M., Brimnes J., Shao L., Dotan I., Nakazawa A., Mayer L. Activation of a unique population of CD8(+) T cells by intestinal epithelial cells. Ann N Y Acad Sci 2004, 1029:22-35.
33. Krishnan S., Warke V.G., Nambiar M.P., Wong H.K., Tsokos G.C., Farber D.L. Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3zeta expression. Blood 2001, 97(12):3851-3859.
34. Abuzakouk M., Carton J., Feighery C., O'Donoghue D.P., Weir D.G., O'Farrelly C. CD4+ CD8+ and CD8alpha+ beta-T lymphocytes in human small intestinal lamina propria. Eur J Gastroenterol Hepatol 1998, 10(4):325-329.
35. Zuckermann F.A. Extrathymic CD4/CD8 double positive T cells. Vet Immunol Immunopathol 1999, 72(1-2):55-66.
36. Parel Y., Chizzolini C. CD4+ CD8+ double positive (DP) T cells in health and disease. Autoimmun Rev 2004, 3(3):215-220.
37. Senju M., Wu K.C., Mahida Y.R., Jewell D.P. Coexpression of CD4 and CD8 on peripheral blood T cells and lamina propria T cells in inflammatory bowel disease by two colour immunofluorescence and flow cytometric analysis. Gut 1991, 32(8):918-922.
38. De Maria A., Malnati M., Moretta A., Pende D., Bottino C., Casorati G., et al. CD3+4-8-WT31-(T cell receptor gamma+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2-responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis. A clonal analysis. Eur J Immunol 1987, 17(12):1815-1819.
39. Iwatani Y., Hidaka Y., Matsuzuka F., Kuma K., Amino N. Intrathyroidal lymphocyte subsets, including unusual CD4+ CD8+ cells and CD3loTCR alpha beta lo/-CD4-CD8-cells, in autoimmune thyroid disease. Clin Exp Immunol 1993, 93(3):430-436.
40. Parel Y., Aurrand-Lions M., Scheja A., Dayer J.M., Roosnek E., Chizzolini C. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum 2007, 56(10):3459-3467.
41. Bonderup O.K., Hansen J.B., Birket-Smith L., Vestergaard V., Teglbjaerg P.S., Fallingborg J. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut 2003, 52(2):248-251.
42. Miehlke S., Madisch A., Karimi D., Wonschik S., Kuhlisch E., Beckmann R., et al. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology 2009, 136(7):2092-2100.